Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sirtuin 6 (SIRT6) messenger RNA (mRNA) is the transcript of the SIRT6 gene, which encodes a critical nuclear enzyme belonging to the sirtuin family of NAD+-dependent deacetylases (NCBI Gene ID: 51337). The SIRT6 protein translated from this mRNA acts as a master regulator of several essential biological processes, including DNA repair, telomere maintenance, and glucose metabolism (UniProt, Q8N6T7). It is particularly noted for its role as a tumor suppressor in many cancers by inhibiting the Warburg effect, although it can also promote cell survival in specific contexts (PubMed, PMID: 23239730). Furthermore, SIRT6 is recognized as a key longevity factor, as its deficiency leads to accelerated aging and its overexpression has been shown to extend lifespan in animal models (Nature, PMID: 22367546). As a therapeutic target, SIRT6 mRNA is primarily addressed through RNA-based modalities such as small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) designed to modulate the expression of the SIRT6 protein (PubMed, PMID: 31515475). While most current pharmacological research focuses on small-molecule modulators of the SIRT6 protein, targeting the mRNA provides a mechanism to control the total cellular abundance of the enzyme, which is useful in treating metabolic disorders and certain malignancies (PubMed, PMID: 30232357). Challenges in targeting SIRT6 mRNA include ensuring tissue-specific delivery and avoiding off-target effects that could disrupt the protein's vital roles in genomic stability (Nature Communications, 2020). Monitoring SIRT6 mRNA levels and downstream markers like H3K9 acetylation serves as a biomarker for assessing the efficacy of these interventions (PubMed, PMID: 21063482).
Modulation of SIRT6 protein expression through RNA interference (RNAi) or antisense-mediated degradation of the mRNA transcript to control cellular enzyme levels.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sirtuin 6 messenger RNA (SIRT6 mRNA) (SIRT6 mRNA).